$42.02
0.801.94%
At close: -
$43.00
0.982.33%
After Hours: Dec 20, 5:29 PM EDT
Verona Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Verona Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $-0.53 | $-0.50 | -6.00 % |
Jun 2024 | 2024-08-08 | $-0.80 | $-0.29 | -175.9 % |
Mar 2024 | 2024-05-09 | $-0.32 | $-0.16 | -100.0 % |
Dec 2023 | 2024-02-29 | $-0.18 | $-0.26 | 30.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $5.62M | $2.01M | 179.8 % |
Dec 2022 | 2023-03-07 | $458.00K | $3.57M | -87.2 % |
Sep 2022 | 2022-11-09 | $0 | $3.57M | -100.0 % |
Sep 2021 | 2021-11-09 | $40.00M | $4.17M | 859.2 % |
Verona Pharma (VRNA) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $-0.53, which missed the estimate of $-0.50.
The Actual Revenue was $5.6M, which beat the estimate of $2M.
Browse earnings estimates, EPS, and revenue on all stocks.